Brawn Biotech Ltd Q1FY23 profit lower at Rs. 13.12 lakhs

BRAWN BIOTECH LTD. has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 3.4022 crores during the period ended June 30, 2022 as compared to Rs. 2.7988 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.1312 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 0.63 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.43 for the period ended June 30, 2022 as compared to Rs. 2.16 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 3.4022 crs	₹2.7988 crs	21.56%
Net Profit	₹0.1312 crs	₹0.63 crs	-79.17%
EPS	₹0.43	₹2.16	-80.09%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 3.4022 crores during the period ended June 30, 2022 as compared to Rs.1.1294 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.1312 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.-0.2181 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.0.43 for the period ended June 30, 2022 as compared to Rs.-0.75 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 3.4022 crs	₹1.1294 crs	201.24%
Net Profit	₹0.1312 crs	₹-0.2181 crs	160.16%
EPS	₹0.43	₹-0.75	157.33%

Shares of BRAWN BIOTECH LTD. was last trading in BSE at Rs. 16.10 as compared to the previous close of Rs. 16.10. The total number of shares traded during the day was 523 in over 15 trades.

The stock hit an intraday high of Rs. 16.10 and intraday low of 15.30. The net turnover during the day was Rs. 8306.00.

Source : Equity Bulls

Keywords

BrawnBiotech Q1FY23 ResultUpdate